lawmakers should revisit that idea when lepage is no longer in office next year..
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
- .
- ..
.
.
lawmakers should revisit that idea when lepage is no longer in office next year..
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
.
.